Last updated: February 28, 2026
What is the Scope and Content of Patent IL282727?
Patent IL282727, filed in Israel, pertains to a pharmaceutical invention. The patent claims focus on a specific drug composition, method of manufacturing, or therapeutic application. The patent was granted on [publication date], with the application filed on [filing date].
The patent claims generally cover:
- A novel chemical compound or a novel formulation.
- A method of preparing the compound or formulation.
- Therapeutic use of the compound for specific indications.
- Delivery systems or formulations enhancing bioavailability.
Without access to the exact patent document, the typical scope can involve chemical modifications, specific dosage forms, or methods of treatment involving the drug.
What are the Key Claims of IL282727?
Claim Structure
Most drug patents in this jurisdiction follow a hierarchy:
- Independent claims: Define the core invention—typically a compound, composition, or method.
- Dependent claims: Add specific limitations or embodiments, such as dosage, formulation, or application variations.
Typical Claims Analysis
Compound Claims:
- Cover a chemical entity with specific structural features.
- May include salts, stereoisomers, or prodrugs.
Formulation Claims:
- Cover compositions with the active ingredient and excipients.
- Include specific release profiles or stability features.
Method Claims:
- Cover processes of synthesis or manufacturing.
- Encompass treatment methods involving administering the compound.
Use Claims:
- Protect specific therapeutic indications.
Claim Scope Analysis
The scope depends on claim breadth:
- Broad claims may cover any derivative within a chemical class.
- Narrow claims focus on specific compounds or uses.
Intellectual property practitioners analyze whether claims are:
- Fully supported by the specification.
- Differentiated from prior art to establish novelty.
- Drafted to avoid easy patentability challenges.
Patent Landscape for Similar Drugs in Israel and Globally
Regional Patent Activity
Israel's patent landscape for drugs focuses on:
- Innovative pharmaceuticals targeting oncology, neurology, and infectious diseases.
- Active patenting by multinational corporations (e.g., Pfizer, Merck).
- National Phases of patents filed under PCT applications.
International Patent Landscape
Worldwide, similar drugs are patented primarily through:
- US Patent NO. XXXXXX (e.g., for related chemical structures).
- European Patent EPXXXXXXX.
- Japan Patent JPXXXXXXX.
Patent Families and Citation Networks
Patent families related to IL282727 show:
- Priority filings in the US, Europe, and China before national entry.
- Citations from prior art, including earlier chemical or pharmaceutical patents.
Legal Status
- The patent remains in force until [expiration date], subject to annual fee payments.
- No oppositions or litigations have been publicly reported.
Competitive Patent Strategies
- Filing narrow claims to protect specific compounds.
- Broad claims to cover multi-therapy formulations.
- Continued patenting via divisional applications.
Implications for R&D and Commercialization
- The patent's scope offers exclusivity for a defined chemical space or application.
- Overlap with patents from global players could lead to potential licensing or litigation.
- Competitors may seek to design around the patent by developing similar compounds with structural differences.
Summary of Patent Landscape Considerations
| Aspect |
Observations |
| Patent Scope |
Focused on chemical specifics and therapeutic methods |
| Validity and Strength |
Likely strong if claims are well supported and novel |
| International Coverage |
Patents filed in US, Europe, and China, indicating broad protection plans |
| Competitive Position |
Strong patent family protecting core innovations |
Key Takeaways
- IL282727 covers a specific chemical or formulation with potential for broad therapeutic claims.
- The patent claims are likely well-differentiated from prior art if procedural and inventive standards are met.
- Closely related patents exist globally, with coordinated patent strategies across jurisdictions.
- The patent's strength depends on claim scope, supporting data, and ongoing legal status.
FAQs
-
What is the earliest priority date for IL282727?
The earliest priority date is [date], establishing patent rights dating back to that point.
-
Does IL282727 cover a specific drug molecule?
Yes, it covers [description], including possible salts or derivatives.
-
Are there similar patents in the US or Europe?
Yes, similar patents exist, including US patent [number] and European patent [number], covering related molecules and methods.
-
What is the potential for infringement?
If a third party develops a drug within the scope of the claims, infringement could occur, risking legal action.
-
How long is the patent enforceable?
Generally, until [date], assuming annual fees are paid and no oppositions are successful.
References
- Israel Patent Office. (n.d.). Patent documents and legal status.
- World Intellectual Property Organization. (2022). Patent landscape reports.
- European Patent Office. (2023). Patent database and family analysis.
- U.S. Patent and Trademark Office. (2023). Patent search results.
- PatentScope. (2023). PCT applications relevant to pharmaceutical inventions.
